Topic Highlight
Copyright ©2006 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. May 14, 2006; 12(18): 2830-2838
Published online May 14, 2006. doi: 10.3748/wjg.v12.i18.2830
Functional findings in irritable bowel syndrome
Iris Posserud, Amanda Ersryd, Magnus Simrén
Iris Posserud, Amanda Ersryd, Magnus Simrén, Department of Internal Medicine, Sahlgrenska University Hospital, Göteborg, Sweden
Correspondence to: Magnus Simrén, Section of Gastroenterology & Hepatology, Department of Internal Medicine, Sahlgrenska University Hospital S-41345 Gothenburg, Sweden. magnus.simren@medicine.gu.se
Telephone: +46-31-3421000 Fax: +46-31-822152
Received: March 25, 2006
Revised: March 28, 2006
Accepted: April 10, 2006
Published online: May 14, 2006

Abstract

The pathophysiology of IBS is complex and still incompletely known. Both central and peripheral factors, including psychosocial factors, abnormal GI motility and secretion, and visceral hypersensitivity, are thought to contribute to the symptoms of IBS. Several studies have demonstrated altered GI motor function in IBS patients and the pattern differs between IBS subgroups based on the predominant bowel pattern. Few studies have so far addressed GI secretion in IBS, but there are some evidence supporting altered secretion in the small intestine of IBS patients. Visceral hypersensitivity is currently considered to be perhaps the most important pathophysiological factor in IBS. Importantly, several external and internal factors can modulate visceral sensitivity, as well as GI motility, and enhanced responsiveness within the GI tract to for instance stress and nutrients has been demonstrated in IBS patients. Today IBS is viewed upon as a disorder of dysregulation of the so-called brain-gut axis, involving abnormal function in the enteric, autonomic and/or central nervous systems, with peripheral alterations probably dominating in some patients and disturbed central processing of signals from the periphery in others.

Key Words: IBS, Gastrointestinal motility, Visceral hypersensitivity, Gastrointestinal secretion, Intestinal gas, Brain-gut axis, Brain imaging, Autonomic nervous system


Citation: Posserud I, Ersryd A, Simrén M. Functional findings in irritable bowel syndrome. World J Gastroenterol 2006; 12(18): 2830-2838
INTRODUCTION

Irritable bowel syndrome (IBS) is characterized by abdominal pain and/or discomfort related to abnormal bowel habits[1]. It is probably the most common disorder encountered by gastroenterologists[2] and also the most common gastrointestinal disorder seen in primary care[3]. A problem in the management of IBS is that there are no structural or biochemical disease markers for these patients. Therefore, various diagnostic criteria have been used to define IBS in clinical practice and, more importantly, in research settings[1]. In the Western world, IBS appears to affect up to 20% of the population at any given time[4-6], although the prevalence figures vary substantially depending on the definition of IBS[7,8]. Due to its high prevalence and, for many patients, chronic nature and incapacitating symptoms the cost of IBS to society is substantial[9].

Despite being very common, the pathophysiology of IBS is far from understood. IBS has for a long time been considered a disorder of disturbed gastrointestinal motility, although uniform motility patterns in IBS have been hard to define. Moreover, motility findings have been difficult to relate to symptoms, especially abdominal pain[10,11]. Beginning in the early 1970s, but progressing rapidly in the 1990s were theories that visceral hyperalgesia independent of enhanced motility could explain the painful symptoms of IBS[12]. More recently, a more integrated model of brain-gut interactions proposes that the central and enteric nervous systems interact and modulate enhanced motility, abnormal sensation and autonomic reactivity: the brain-gut axis. In context with this model, psychosocial factors, rather than being a cause of IBS, are regarded as contributing to the predisposition, precipitation and perpetuation of IBS symptoms, and affect the clinical outcome[13]. However, despite the increasing knowledge of the pathophysiological and clinical aspects of IBS, there are a substantial number of unresolved issues.

During recent years the interest in finding relevant alterations in patients with IBS in the function of the gastrointestinal tract, as well as in the central and autonomic nervous system has increased. The trend is now that there is less focus on pure gastrointestinal alterations and instead more focus on interactions between exacerbating factors and gastrointestinal function, as well as on interaction between different parts of our nervous system and the gastrointestinal tract. This article will review the literature on findings in IBS patients supporting disturbed function in the gastrointestinal tract as well as its interaction with the central and autonomic nervous systems.

ALTERED GASTROINTESTINAL MOTILITY
Esophageal and gastric motility

Most studies of motility in functional bowel disorders have focused on the large and small bowel, although there are also reports on disturbed motility in the esophagus and the stomach. Patients with IBS demonstrate, for instance, lower pressure in the lower esophageal sphincter and more esophageal contraction abnormalities than healthy subjects[14]. Furthermore, patients with contraction abnormalities in the esophagus often report symptoms compatible with IBS[15]. There are several studies of gastric emptying in patients with IBS. These have come to somewhat different conclusions, with some of the older studies being unable to detect an abnormality[16-18], whereas some of the more recent studies found abnormal gastric emptying in at least a subset of IBS patients[19-22]. Moreover, the presence of gastroparesis in IBS was found to be related to small bowel dysmotility[23]. In a recent large-scale study, delayed gastric emptying was found in IBS patients with overlapping dyspepsia, but not in those without dyspeptic symptoms[24]. Some studies have also used electrogastrography (EGG) in patients with IBS finding a nice correlation between lack of increased postprandial EGG amplitude and delayed gastric emptying in a subset of IBS patients[25], whereas another study found EGG abnormalities only in IBS patients with concurrent dyspeptic symptoms[26]. The conclusion of these studies seems to be that altered esophageal and gastric motor function is more related to the presence of upper GI symptoms than to IBS per se, even though a significant overlap between upper GI symptoms and IBS exists[27].

Small intestinal motility

The motor patterns of the small bowel in man are rather well characterized[28], but marked inter- and intraindividual variations make interpretation difficult[29,30]. In the late 1970s technological advances made it possible to accurately record small bowel motility in man. Thompson and co-workers, using a radiotelemetry capsule system, reported abnormal small-bowel motility in a patient with “irritable colon”[31], but a follow-up study using a similar recording system failed to confirm this[32]. Subsequent studies have focused on the periodicity of the migrating motor complex (MMC) (i.e. the interval between successive MMC cycles), as well as finding specific motor patterns in IBS and relating these patterns to symptoms. In diarrhea prone subjects, the periodicity of the MMC during daytime has been found to be shorter[33,34], but longer in IBS patients with predominant constipation[35], although these are not consistent findings[36,37]. Increased frequency of clustered activity has been found in some[33,34,38], but not all studies[36,37,39]. Of more interest perhaps, are correlations between symptoms in IBS patients and certain motility patterns, such as clustered activity (e.g. “discrete clustered contractions”) and prolonged propagated contractions[33,34], but likewise, these findings have been partly[37] or totally[36] rejected by others. Furthermore, IBS patients have been found to have enhanced perception of physiological intestinal motility, such as the activity front[40]. There also appears to be a relationship between heightened sensitivity to distension of the small intestine and postprandial jejunal motor abnormalities in IBS patients[41]. An increased contraction frequency postprandially has been demonstrated in diarrhea and constipation predominant IBS[42], and in a study by Schmidt et al diarrhea prone IBS patients had more aborally propagated contractions in phase II and postprandially than the controls[37]. The contraction amplitude has, if anything, been shown to be increased in IBS patients with diarrhea[37] and reduced in those with constipation[35,42]. Our group has used high-resolution manometry in the small intestine with closely spaced recording points to evaluate the propagation pattern of individual pressure waves[43]. A study in IBS patients and healthy controls disclosed a higher proportion of duodenal individual pressure waves that propagated in a retrograde direction in IBS, especially in the postprandial phase. Moreover, when combining this high-resolution analysis with more conventional manometry analysis, abnormal findings were found in the majority of IBS patients[38].

Motility disturbances of the small bowel have also been demonstrated indirectly in transit studies, with rather uniform findings of accelerated transit through the small bowel in diarrhea predominant IBS[44,45] and delayed transit in constipation predominant IBS[18,44]. Small intestinal bacterial overgrowth (SIBO) is a condition caused by an abnormal number of bacteria in the small intestine, which is a common complication of severe small intestinal motor dysfunction[46,47]. Recently, provocative studies, using the lactulose hydrogen breath test[48], have proposed that SIBO is present in approximately 80% of IBS patients[49] and that this alteration responds favourably to antibiotic treatment with symptom improvement[50]. Moreover, the presence of SIBO in IBS patients has been proposed to be related to small intestinal motor abnormalities[51]. However, contradictory results exist and the relevance of SIBO in IBS is still open to debate[52-54].

To conclude, there is evidence of disturbed small bowel motility in IBS patients as a group, but no uniform motility pattern has been found and a consistent correlation between motility findings and symptoms has been difficult to demonstrate. Whether the observed motility abnormalities of the small intestine in IBS are due to factors related to the enteric or the central nervous system is not clear, but there is evidence to suggest that both may be true[35,39,55].

Colonic motility

Considerable effort has been made to find a specific abnormality in the myoelectrical and/or motor patterns of colon in IBS. However, a primary role for colonic dysmotility in the pathophysiology of IBS has been hard to demonstrate. Some of these difficulties may be explained by the fact that myoelectrical and motor events from the colon are less predictable and less well studied than corresponding events elsewhere in the gastrointestinal tract[56,57]. In the 1970s Snape and colleagues reported on abnormal colonic myoelectrical activity in IBS (3 cycle/min pattern)[58,59], but subsequent studies failed to confirm this pattern to be specific for IBS[60,61]. Instead, since this pattern was demonstrated to be equally common among psychoneurotics without gastrointestinal symptoms it was suggested that this abnormality represented a colonic response to stress rather than being related to IBS[62]. Other techniques have focused on colonic spike patterns and demonstrated variations in the incidence of these[63], but whether these findings simply represent a non-specific response to diarrhea is not clear, since appropriate non-IBS controls have not been studied.

Several studies of basal colonic motility with intraluminal pressure recordings have not been able to demonstrate an abnormal pattern in IBS as compared to appropriate controls or differences between IBS patients with different symptomatology[17,64], but this has to some extent been contradicted in recent studies of colonic motility[65,66]. Some of the earlier studies were, however, able to detect frequent sigmoid contractions with high amplitude in association with pain reports from some of the IBS patients studied (“spastic colon”), although no group differences in rectosigmoid motility between IBS patients and controls could be detected[67]. Also, some recent studies have found an increased frequency of high-amplitude propagating contractions (HAPC) in the colon in non-constipated IBS patients[65,68,69], and more interestingly an association between pain episodes and HAPCs[65,70], possibly related to the presence of visceral hypersensitivity in IBS. Somewhat more consistent has been the finding that IBS patients seem to have an exaggerated and prolonged postprandial myoelectrical and motor response than healthy volunteers[17,65,71,72], even though negative studies also exist[66,73].

The normal motor response in the colon after nutrient administration is an increase in phasic motor activity and a progressive increase in tone as well[74]. At least two studies have failed to detect an abnormal colonic tone response after meal intake in IBS patients[66,75]. However, there are some recent data supporting altered gastrointestinal reflex activity in IBS patients, by demonstrating abnormal recto-sigmoid tone response following a low-caloric meal[76], or as an attenuated rectal tone response to colonic distension (“the colorectal tonic reflex”)[77,78]. Hopefully these interesting studies will be followed by other investigations evaluating gastrointestinal reflex activity within the gastrointestinal tract, thereby providing new important information regarding neuromuscular function within the gastrointestinal tract in IBS patients. As in the small intestine motility alterations have also been demonstrated using transit studies. Transit through the colon influences the bowel habit of the patient[79,80], and differences exist in colon transit between IBS subgroups based on the predominant bowel habit[44,81].

To conclude, there is some evidence to suggest a disordered colonic motility in IBS, even though no uniform colonic motor pattern of this patient group is evident. Of great relevance to the symptomatology is probably the exaggerated colonic motor response to physiological stimuli such as food and, perhaps also stress and emotions in IBS[61,82], which together with an enhanced visceral sensitivity might be deleterious for these patients. Alterations in gastrointestinal reflex activity in IBS patients seem plausible, but follow-up studies are needed.

ABNORMAL GAS HANDLING

In patients with IBS complaints of “too much gas” causing abdominal pain and bloating is very common, and this has been proposed to be secondary to disordered intestinal motility in combination with an abnormal GI sensitivity, rather than caused by abnormal volume or composition of intestinal gas[83]. However, an abnormal colonic fermentation in IBS has been demonstrated in one study[84], but needs to be repeated by other groups. Of great interest, patients with IBS complaining of bloating has been found to have impaired transit of exogenous gas loads, and the following gas retention reproduced their symptoms[85]. Importantly, this abnormality can be modulated by nutrients[86,87], physical activity[88] and body posture[89]. In follow-up studies using scintigraphy the small intestine seemed to be responsible for the ineffective gas propulsion in patients complaining of bloating[90], and altered gastrointestinal reflex activity in IBS patients might also be involved in the abnormal gas handling[91].

These findings tell us that IBS patients do not necessarily need to produce more gas in order to have gas related symptoms, but these may instead be due to motor dysfunction, resulting in a transport problem, and an enhanced visceral sensitivity.

ALTERED GASTROINTESTINAL SECRETION

Few studies have so far addressed GI secretion in IBS, partly due to methodological problems in assessing gastrointestinal secretion. However, there are some evidences supporting altered secretion in the small intestine of IBS. An old study demonstrated that patients with IBS have enhanced intestinal secretion in response to perfused bile acids in the ileum, relative to controls[92]. Our group has used potential difference measurements in the small intestine as an indirect measure of secretion in the small intestine[93], and in preliminary studies found an enhanced reactivity of the secretory component of the MMC in the small intestine in diarrhea-predominant IBS and to some extent also in constipation predominant IBS[94]. Ongoing studies will further evaluate the importance of secretory abnormalities in patients with IBS and the relevance for symptoms.

VISCERAL HYPERSENSITIVITY

Since James Ritchie in 1973 demonstrated colonic hyperalgesia by inflating balloons in the sigmoid colon in patients with “the irritable colon syndrome”[95] numerous reports on visceral hypersensitivity in IBS have appeared. Lowered perception thresholds for balloon distension in IBS patients have not only been demonstrated in the rectum[96] and colon[97], but also in the esophagus[98,99], stomach[100] and the small intestine[101,102]. These findings support a generalized enhancement of gastrointestinal sensitivity in IBS patients. However, a recent investigation has implicated that the hypersensitivity seems to be pan-intestinal for those with multiple sites of their symptoms, whereas it was restricted to a specific organ in those with more localized symptoms[103]. Whether IBS patients have a general hypersensitivity remains debatable since divergent results exist regarding somatic sensitivity[104-106]. Patients with IBS also show an altered viscerosomatic referral pattern as another indicator of disturbed processing of viscerosensory information[107]. However, visceral perception is not abnormal in all patients with IBS[100,108] and there is a considerable overlap in colonic pain thresholds between IBS patients and healthy controls [109]. Moreover, the relationship to the symptom profile of the patient is controversial[108,110-112].

In an attempt to find a biological marker for IBS, Mertz et al evaluated different aspects of rectal perception in a group of IBS patients. They found that 94 percent of patients showed altered rectal perception in the form of lowered thresholds for aversive sensations (discomfort), increased intensity of sensations or altered viscerosomatic referral[96]. Also, a more recent study has come to the same conclusion and proposed that rectal sensitivity testing is useful to confirm the diagnosis of IBS and to discriminate IBS from other causes of abdominal pain[113]. The proposal that altered rectal perception is a biological marker for IBS has, however, been questioned and the importance of psychological factors in visceral perception has been stressed instead[114]. Psychological factors might certainly be of great importance in studies dealing with visceral sensations, and response bias[115] may influence results from balloon distension studies. A different conclusion can be drawn from a study by Corsetti et al, who showed that there was no difference between patients and healthy controls in identifying regular balloon inflations mixed with sham distensions, suggesting that the increased frequency of sensations often reported by IBS patients are not due to psychological response bias[116]. On the other hand, Whitehead and co-workers found that thresholds were correlated with psychological measures of anxiety and somatization[117]. However, in that study sexual abuse, reported to be associated with IBS[118], did not contribute significantly to the rectal pain sensitivity, which has been confirmed recently[119]. One explanation for these somewhat discrepant results may be that IBS patients demonstrate two different perceptual alterations: hypersensitivity to rectal distension, which is proposed to be largely due to peripheral alterations, and hypervigilance towards labeling a wide range of visceral stimuli in negatively affective terms, which is more related to psychological alterations[120].

A drawback with many of the studies assessing visceral perception in IBS is that they are made under fasting and non-stimulated conditions, under which patients normally do not report severe symptoms. However, it has been shown that repetitive sigmoid distensions - thought to imitate increased colonic motility after food intake[17], emotions[82] and stress[61] - resulted in hyperalgesia and increased viscerosomatic referral during rectal distensions in IBS patients. These findings were proposed to reflect a central sensitization of the dorsal horn neurons[121]. These data fit well with findings from studies evaluating the effects of rectal distension on spinal transmission of nociceptive signals, using a somatic cutaneomuscular flexion reflex (RIII reflex)[122], where IBS patients have an altered response[123]. Whether this is designated to changes in electrophysiological properties of the spinal nociceptive neurones or failure in the inhibition of nociceptive signals in spinal nerves is yet to be answered.

Patients with IBS often describe a correlation between their symptoms and stress, and they seem to be more susceptible to stressful events of daily life[124]. Using different methodologies, several studies now exist that demonstrate an altered visceral perceptual response in IBS patients relative to control subjects after and during stress[125-127], which might be of relevance for stress-related symptoms in IBS patients. Postprandial worsening of symptoms, as well as adverse reactions to one or more foods is common in IBS patients[128]. The effects of nutrients on colorectal sensitivity have been investigated in healthy volunteers and rectal sensitivity increases after nutrient ingestion[129]. Fat is also the main stimulus for this sensory component of the gastrocolonic response[130]. Recently we demonstrated enhancement of the colonic sensitivity in IBS patients after duodenal lipid administration as compared with healthy controls[75]. This finding has thereafter also been reproduced by other groups assessing the effect of duodenal lipid administration on rectal sensory function[131,132], making it fair to state that patients with IBS seem to have an exaggerated sensory component of the gastrocolonic response.

Visceral hypersensitivity may also be affected by motor characteristics and biomechanical properties of the gut, but studies assessing for instance rectal compliance have come to somewhat inconclusive results[108,133,134]. Moreover, a study using impedance planimetry found no clear evidence of altered biomechanical properties in the rectum in patients with IBS and hypersensitivity[135]. However, more studies assessing the relationship between sensory and motor characteristics and biomechanical properties of the gastrointestinal tract in IBS patients are needed.

To conclude, visceral hypersensitivity is currently considered to be perhaps the most important pathophysiological factor in IBS. Importantly, several external and internal factors can modulate visceral sensitivity. The link between visceral hypersensitivity and specific symptoms in IBS deserves further studies.

DYSREGULATION OF THE BRAIN-GUT AXIS

The brain-gut axis is a model describing bidirectional pathways linking emotional and cognitive centres in the brain with visceral afferent sensation and intestinal function. Several observations have led to the hypothesis of a dysfunctional brain-gut axis in the pathophysiology of IBS[136-138]. Brain imaging techniques such as functional magnetic resonance imaging (fMRI) and positron emission tomography (PET) have been used to investigate brain response during visceral stimulation with rectal distensions. Despite contradicting results, several studies indicate differences between IBS patients and healthy controls in activation of different pain processing regions such as the anterior cingulate cortex (ACC), thalamus, insula and prefrontal cortex (PFC)[139].

Using PET, Silverman et al initially reported that painful rectal distension in IBS patients resulted in reduced ACC activity but enhanced activity in the PFC during anticipation of rectal pain suggesting a hypervigilance towards the stimulation and a failure to activate endogenous pain inhibition systems[140]. However, Mertz et al later published an fMRI study showing increased activity in the ACC indicating a normal activation pattern but a heightened sensitivity of the brain-gut axis[141]. Several brain imaging studies have been published thereafter with somewhat divergent results, with reports of increased activity in the insula, PFC and thalamus[142,143], as well as in the cingular cortex[142,144,145], but also decreased activity in the insula, amygdala and striatum[146]. The discrepancies in results are probably explained by factors such as small study populations and pooling of results from heterogeneous groups, as well as the use of different methodologies[147]. It has for instance been demonstrated that male and female IBS patients show differences in activation of brain regions[148,149], just like the activation pattern differs between IBS subgroups based on the predominant bowel habit[150]. The psychological state of the patient is also important since emotional status has been shown to modulate brain activation patterns[151].Interestingly, changes in some brain regions have also been associated with treatment response in IBS[152]. In addition to brain imaging, IBS patients have also shown different results than healthy controls in studies using electroencephalography (EEG)[153,154] and evoked potentials[155,156].

Central nervous system communication with the gut is mediated through the parasympathetic and sympathetic pathways of the autonomic nervous system (ANS) by modulation of the enteric nervous system. Several studies have reported autonomic dysfunction in IBS[157-161]. The results are inconsistent, but increased sympathetic and decreased parasympathetic activity in IBS patients compared with healthy controls are the most frequently reported differences[162-166]. Again, the contradictory results may partly be due to varying experimental designs with differences in study populations. Anxiety and depression influences autonomic function in IBS[167], and there also seem to be discrepancies between different subgroups of IBS patients[162,165,168]. Recently Tillisch et al also showed gender differences in ANS response to visceral stimulus, with more prominent alterations in male IBS patients[169].

Another important system in the communication between the brain and the gut is the hypothalamic-pituitary-adrenal (HPA) axis, with important effects on GI motility, sensation and immune function[170]. Activation of this system takes place in response to both physical and psychological stressors[171]. Since patients with IBS often report stress-related symptoms[124], it has been a logical step to evaluate the HPA axis and its effect on GI function in IBS. Also here results are divergent with investigations reporting attenuated[172], normal[125] and enhanced reactivity[127,173] of the HPA-axis in IBS patients in response to various stressors. Again, different study designs, patient characteristics and other factors might be the explanation for the somewhat heterogeneous results[174].

To conclude, there appears to be alterations along the brain-gut axis and in autonomic nervous function in patients with IBS. However, there are discrepancies between existing studies, and in future studies standardization of the methodology, as well as strict inclusion criteria and evaluation of larger patient groups will enhance our understanding of the interaction between the gut and different parts of our nervous system.

CONCLUSION

The pathophysiology of IBS is complex and still incompletely known. Both central and peripheral factors, including psychosocial factors, abnormal GI motility and secretion, and visceral hypersensitivity, are thought to contribute to the symptoms of IBS. However, in order to be able to find new treatment alternatives for this big patients group more knowledge about the pathophysiology of IBS is needed.

Footnotes

S- Editor Pan BR E- Editor Bi L

References
1.  Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Müller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut. 1999;45 Suppl 2:II43-II47.  [PubMed]  [DOI]
2.  Harvey RF, Salih SY, Read AE. Organic and functional disorders in 2000 gastroenterology outpatients. Lancet. 1983;1:632-634.  [PubMed]  [DOI]
3.  Thompson WG, Heaton KW, Smyth GT, Smyth C. Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut. 2000;46:78-82.  [PubMed]  [DOI]
4.  Heaton KW, O'Donnell LJ, Braddon FE, Mountford RA, Hughes AO, Cripps PJ. Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters. Gastroenterology. 1992;102:1962-1967.  [PubMed]  [DOI]
5.  Longstreth GF, Wolde-Tsadik G. Irritable bowel-type symptoms in HMO examinees. Prevalence, demographics, and clinical correlates. Dig Dis Sci. 1993;38:1581-1589.  [PubMed]  [DOI]
6.  Agréus L, Svärdsudd K, Nyrén O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology. 1995;109:671-680.  [PubMed]  [DOI]
7.  Kay L, Jørgensen T, Jensen KH. The epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors. J Intern Med. 1994;236:23-30.  [PubMed]  [DOI]
8.  Saito YA, Locke GR, Talley NJ, Zinsmeister AR, Fett SL, Melton LJ 3rd. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol. 2000;95:2816-2824.  [PubMed]  [DOI]
9.  Wells NE, Hahn BA, Whorwell PJ. Clinical economics review: irritable bowel syndrome. Aliment Pharmacol Ther. 1997;11:1019-1030.  [PubMed]  [DOI]
10.  McKee DP, Quigley EM. Intestinal motility in irritable bowel syndrome: is IBS a motility disorder Part 2. Motility of the small bowel, esophagus, stomach, and gall-bladder. Dig Dis Sci. 1993;38:1773-1782.  [PubMed]  [DOI]
11.  McKee DP, Quigley EM. Intestinal motility in irritable bowel syndrome: is IBS a motility disorder Part 1. Definition of IBS and colonic motility. Dig Dis Sci. 1993;38:1761-1772.  [PubMed]  [DOI]
12.  Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology. 1994;107:271-293.  [PubMed]  [DOI]
13.  Drossman DA. Review article: an integrated approach to the irritable bowel syndrome. Aliment Pharmacol Ther. 1999;13 Suppl 2:3-14.  [PubMed]  [DOI]
14.  Whorwell PJ, Clouter C, Smith CL. Oesophageal motility in the irritable bowel syndrome. Br Med J (Clin Res Ed). 1981;282:1101-1102.  [PubMed]  [DOI]
15.  Clouse RE, Eckert TC. Gastrointestinal symptoms of patients with esophageal contraction abnormalities. Dig Dis Sci. 1986;31:236-240.  [PubMed]  [DOI]
16.  Acharya U, Waite N, Howlett P, Tanner AR, Smith CL. Failure to demonstrate altered gastric emptying in irritable bowel syndrome. Dig Dis Sci. 1983;28:889-892.  [PubMed]  [DOI]
17.  Narducci F, Bassotti G, Granata MT, Pelli MA, Gaburri M, Palumbo R, Morelli A. Colonic motility and gastric emptying in patients with irritable bowel syndrome. Effect of pretreatment with octylonium bromide. Dig Dis Sci. 1986;31:241-246.  [PubMed]  [DOI]
18.  Nielsen OH, Gjørup T, Christensen FN. Gastric emptying rate and small bowel transit time in patients with irritable bowel syndrome determined with 99mTc-labeled pellets and scintigraphy. Dig Dis Sci. 1986;31:1287-1291.  [PubMed]  [DOI]
19.  van Wijk HJ, Smout AJ, Akkermans LM, Roelofs JM, ten Thije OJ. Gastric emptying and dyspeptic symptoms in the irritable bowel syndrome. Scand J Gastroenterol. 1992;27:99-102.  [PubMed]  [DOI]
20.  Charles F, Phillips SF, Camilleri M, Thomforde GM. Rapid gastric emptying in patients with functional diarrhea. Mayo Clin Proc. 1997;72:323-328.  [PubMed]  [DOI]
21.  Caballero-Plasencia AM, Valenzuela-Barranco M, Herrerías-Gutiérrez JM, Esteban-Carretero JM. Altered gastric emptying in patients with irritable bowel syndrome. Eur J Nucl Med. 1999;26:404-409.  [PubMed]  [DOI]
22.  Portincasa P, Moschetta A, Baldassarre G, Altomare DF, Palasciano G. Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome. World J Gastroenterol. 2003;9:2293-2299.  [PubMed]  [DOI]
23.  Evans PR, Bak YT, Shuter B, Hoschl R, Kellow JE. Gastroparesis and small bowel dysmotility in irritable bowel syndrome. Dig Dis Sci. 1997;42:2087-2093.  [PubMed]  [DOI]
24.  Stanghellini V, Tosetti C, Barbara G, De Giorgio R, Cogliandro L, Cogliandro R, Corinaldesi R. Dyspeptic symptoms and gastric emptying in the irritable bowel syndrome. Am J Gastroenterol. 2002;97:2738-2743.  [PubMed]  [DOI]
25.  van der Voort IR, Osmanoglou E, Seybold M, Heymann-Mönnikes I, Tebbe J, Wiedenmann B, Klapp BF, Mönnikes H. Electrogastrography as a diagnostic tool for delayed gastric emptying in functional dyspepsia and irritable bowel syndrome. Neurogastroenterol Motil. 2003;15:467-473.  [PubMed]  [DOI]
26.  Leahy A, Besherdas K, Clayman C, Mason I, Epstein O. Abnormalities of the electrogastrogram in functional gastrointestinal disorders. Am J Gastroenterol. 1999;94:1023-1028.  [PubMed]  [DOI]
27.  Corsetti M, Caenepeel P, Fischler B, Janssens J, Tack J. Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia. Am J Gastroenterol. 2004;99:1152-1159.  [PubMed]  [DOI]
28.  Husebye E. The patterns of small bowel motility: physiology and implications in organic disease and functional disorders. Neurogastroenterol Motil. 1999;11:141-161.  [PubMed]  [DOI]
29.  Kerlin P, Phillips S. Variability of motility of the ileum and jejunum in healthy humans. Gastroenterology. 1982;82:694-700.  [PubMed]  [DOI]
30.  Kellow JE, Borody TJ, Phillips SF, Tucker RL, Haddad AC. Human interdigestive motility: variations in patterns from esophagus to colon. Gastroenterology. 1986;91:386-395.  [PubMed]  [DOI]
31.  Thompson DG, Laidlow JM, Wingate DL. Abnormal small-bowel motility demonstrated by radiotelemetry in a patient with irritable colon. Lancet. 1979;2:1321-1323.  [PubMed]  [DOI]
32.  Kingham JG, Bown R, Colson R, Clark ML. Jejunal motility in patients with functional abdominal pain. Gut. 1984;25:375-380.  [PubMed]  [DOI]
33.  Kellow JE, Phillips SF. Altered small bowel motility in irritable bowel syndrome is correlated with symptoms. Gastroenterology. 1987;92:1885-1893.  [PubMed]  [DOI]
34.  Kellow JE, Gill RC, Wingate DL. Prolonged ambulant recordings of small bowel motility demonstrate abnormalities in the irritable bowel syndrome. Gastroenterology. 1990;98:1208-1218.  [PubMed]  [DOI]
35.  Kellow JE, Eckersley GM, Jones M. Enteric and central contributions to intestinal dysmotility in irritable bowel syndrome. Dig Dis Sci. 1992;37:168-174.  [PubMed]  [DOI]
36.  Gorard DA, Libby GW, Farthing MJ. Ambulatory small intestinal motility in 'diarrhoea' predominant irritable bowel syndrome. Gut. 1994;35:203-210.  [PubMed]  [DOI]
37.  Schmidt T, Hackelsberger N, Widmer R, Meisel C, Pfeiffer A, Kaess H. Ambulatory 24-hour jejunal motility in diarrhea-predominant irritable bowel syndrome. Scand J Gastroenterol. 1996;31:581-589.  [PubMed]  [DOI]
38.  Simrén M, Castedal M, Svedlund J, Abrahamsson H, Björnsson E. Abnormal propagation pattern of duodenal pressure waves in the irritable bowel syndrome (IBS) [correction of (IBD)]. Dig Dis Sci. 2000;45:2151-2161.  [PubMed]  [DOI]
39.  Quigley EM, Donovan JP, Lane MJ, Gallagher TF. Antroduodenal manometry. Usefulness and limitations as an outpatient study. Dig Dis Sci. 1992;37:20-28.  [PubMed]  [DOI]
40.  Kellow JE, Eckersley CM, Jones MP. Enhanced perception of physiological intestinal motility in the irritable bowel syndrome. Gastroenterology. 1991;101:1621-1627.  [PubMed]  [DOI]
41.  Evans PR, Bennett EJ, Bak YT, Tennant CC, Kellow JE. Jejunal sensorimotor dysfunction in irritable bowel syndrome: clinical and psychosocial features. Gastroenterology. 1996;110:393-404.  [PubMed]  [DOI]
42.  Small PK, Loudon MA, Hau CM, Noor N, Campbell FC. Large-scale ambulatory study of postprandial jejunal motility in irritable bowel syndrome. Scand J Gastroenterol. 1997;32:39-47.  [PubMed]  [DOI]
43.  Björnsson ES, Abrahamsson H. Interdigestive gastroduodenal manometry in humans. Indication of duodenal phase III as a retroperistaltic pump. Acta Physiol Scand. 1995;153:221-230.  [PubMed]  [DOI]
44.  Cann PA, Read NW, Brown C, Hobson N, Holdsworth CD. Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns. Gut. 1983;24:405-411.  [PubMed]  [DOI]
45.  Jian R, Najean Y, Bernier JJ. Measurement of intestinal progression of a meal and its residues in normal subjects and patients with functional diarrhoea by a dual isotope technique. Gut. 1984;25:728-731.  [PubMed]  [DOI]
46.  Mann SD, Debinski HS, Kamm MA. Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults. Gut. 1997;41:675-681.  [PubMed]  [DOI]
47.  Vantrappen G, Janssens J, Hellemans J, Ghoos Y. The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest. 1977;59:1158-1166.  [PubMed]  [DOI]
48.  Rhodes JM, Middleton P, Jewell DP. The lactulose hydrogen breath test as a diagnostic test for small-bowel bacterial overgrowth. Scand J Gastroenterol. 1979;14:333-336.  [PubMed]  [DOI]
49.  Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol. 2000;95:3503-3506.  [PubMed]  [DOI]
50.  Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. Am J Gastroenterol. 2003;98:412-419.  [PubMed]  [DOI]
51.  Pimentel M, Soffer EE, Chow EJ, Kong Y, Lin HC. Lower frequency of MMC is found in IBS subjects with abnormal lactulose breath test, suggesting bacterial overgrowth. Dig Dis Sci. 2002;47:2639-2643.  [PubMed]  [DOI]
52.  Posserud I, Ringström G, Stotzer PO, Björnsson ES, Abrahamsson H, Simrén M. Small intestinal bacterial overgrowth (SIBO) in irritable bowel syndrome (IBS). Neurogastroenterol Motil. 2004;16:839.  [PubMed]  [DOI]
53.  Simrén M, Stotzer PO. Use and abuse of hydrogen breath tests. Gut. 2006;55:297-303.  [PubMed]  [DOI]
54.  Walters B, Vanner SJ. Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls. Am J Gastroenterol. 2005;100:1566-1570.  [PubMed]  [DOI]
55.  Kumar D, Wingate DL. The irritable bowel syndrome: a paroxysmal motor disorder. Lancet. 1985;2:973-977.  [PubMed]  [DOI]
56.  Sarna SK. Physiology and pathophysiology of colonic motor activity (2). Dig Dis Sci. 1991;36:998-1018.  [PubMed]  [DOI]
57.  Sarna SK. Physiology and pathophysiology of colonic motor activity (1). Dig Dis Sci. 1991;36:827-862.  [PubMed]  [DOI]
58.  Snape WJ Jr, Carlson GM, Cohen S. Colonic myoelectric activity in the irritable bowel syndrome. Gastroenterology. 1976;70:326-330.  [PubMed]  [DOI]
59.  Snape WJ Jr, Carlson GM, Matarazzo SA, Cohen S. Evidence that abnormal myoelectrical activity produces colonic motor dysfunction in the irritable bowel syndrome. Gastroenterology. 1977;72:383-387.  [PubMed]  [DOI]
60.  Sarna S, Latimer P, Campbell D, Waterfall WE. Effect of stress, meal and neostigmine on rectosigmoid electrical control activity (ECA) in normals and in irritable bowel syndrome patients. Dig Dis Sci. 1982;27:582-591.  [PubMed]  [DOI]
61.  Welgan P, Meshkinpour H, Hoehler F. The effect of stress on colon motor and electrical activity in irritable bowel syndrome. Psychosom Med. 1985;47:139-149.  [PubMed]  [DOI]
62.  Latimer P, Sarna S, Campbell D, Latimer M, Waterfall W, Daniel EE. Colonic motor and myoelectrical activity: a comparative study of normal subjects, psychoneurotic patients, and patients with irritable bowel syndrome. Gastroenterology. 1981;80:893-901.  [PubMed]  [DOI]
63.  Bueno L, Fioramonti J, Ruckebusch Y, Frexinos J, Coulom P. Evaluation of colonic myoelectrical activity in health and functional disorders. Gut. 1980;21:480-485.  [PubMed]  [DOI]
64.  Katschinski M, Lederer P, Ellermann A, Ganzleben R, Lux G, Arnold R. Myoelectric and manometric patterns of human rectosigmoid colon in irritable bowel syndrome and diverticulosis. Scand J Gastroenterol. 1990;25:761-768.  [PubMed]  [DOI]
65.  Chey WY, Jin HO, Lee MH, Sun SW, Lee KY. Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea. Am J Gastroenterol. 2001;96:1499-1506.  [PubMed]  [DOI]
66.  Vassallo MJ, Camilleri M, Phillips SF, Steadman CJ, Talley NJ, Hanson RB, Haddad AC. Colonic tone and motility in patients with irritable bowel syndrome. Mayo Clin Proc. 1992;67:725-731.  [PubMed]  [DOI]
67.  Chaudhary NA, Truelove SC. Human colonic motility: a comparative study of normal subjects, patients with ulcerative colitis, and patients with the irritable colon syndrome. I. Resting patterns of motility. Gastroenterology. 1961;40:1-17.  [PubMed]  [DOI]
68.  Bassotti G, de Roberto G, Chistolini F, Sietchiping-Nzepa F, Morelli O, Morelli A. Twenty-four-hour manometric study of colonic propulsive activity in patients with diarrhea due to inflammatory (ulcerative colitis) and non-inflammatory (irritable bowel syndrome) conditions. Int J Colorectal Dis. 2004;19:493-497.  [PubMed]  [DOI]
69.  Clemens CH, Samsom M, Van Berge Henegouwen GP, Smout AJ. Abnormalities of left colonic motility in ambulant nonconstipated patients with irritable bowel syndrome. Dig Dis Sci. 2003;48:74-82.  [PubMed]  [DOI]
70.  Clemens CH, Samsom M, Roelofs JM, van Berge Henegouwen GP, Smout AJ. Association between pain episodes and high amplitude propagated pressure waves in patients with irritable bowel syndrome. Am J Gastroenterol. 2003;98:1838-1843.  [PubMed]  [DOI]
71.  Sullivan MA, Cohen S, Snape WJ Jr. Colonic myoelectrical activity in irritable-bowel syndrome. Effect of eating and anticholinergics. N Engl J Med. 1978;298:878-883.  [PubMed]  [DOI]
72.  Rogers J, Henry MM, Misiewicz JJ. Increased segmental activity and intraluminal pressures in the sigmoid colon of patients with the irritable bowel syndrome. Gut. 1989;30:634-641.  [PubMed]  [DOI]
73.  Bassotti G, Sietchiping-Nzepa F, De Roberto G, Chistolini F, Morelli A. Colonic regular contractile frequency patterns in irritable bowel syndrome: the 'spastic colon' revisited. Eur J Gastroenterol Hepatol. 2004;16:613-617.  [PubMed]  [DOI]
74.  Steadman CJ, Phillips SF, Camilleri M, Haddad AC, Hanson RB. Variation of muscle tone in the human colon. Gastroenterology. 1991;101:373-381.  [PubMed]  [DOI]
75.  Simrén M, Abrahamsson H, Björnsson ES. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome. Gut. 2001;48:20-27.  [PubMed]  [DOI]
76.  Di Stefano M, Miceli E, Missanelli A, Mazzocchi S, Corazza GR. Meal induced rectosigmoid tone modification: a low caloric meal accurately separates functional and organic gastrointestinal disease patients. Gut. 2006;55:1409-1414.  [PubMed]  [DOI]
77.  Ng C, Danta M, Prott G, Badcock CA, Kellow J, Malcolm A. Modulatory influences on antegrade and retrograde tonic reflexes in the colon and rectum. Am J Physiol Gastrointest Liver Physiol. 2004;287:G962-G966.  [PubMed]  [DOI]
78.  Ng C, Danta M, Kellow J, Badcock CA, Hansen R, Malcolm A. Attenuation of the colorectal tonic reflex in female patients with irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2005;289:G489-G494.  [PubMed]  [DOI]
79.  van der Sijp JR, Kamm MA, Nightingale JM, Britton KE, Mather SJ, Morris GP, Akkermans LM, Lennard-Jones JE. Radioisotope determination of regional colonic transit in severe constipation: comparison with radio opaque markers. Gut. 1993;34:402-408.  [PubMed]  [DOI]
80.  Vassallo M, Camilleri M, Phillips SF, Brown ML, Chapman NJ, Thomforde GM. Transit through the proximal colon influences stool weight in the irritable bowel syndrome. Gastroenterology. 1992;102:102-108.  [PubMed]  [DOI]
81.  Charles F, Camilleri M, Phillips SF, Thomforde GM, Forstrom LA. Scintigraphy of the whole gut: clinical evaluation of transit disorders. Mayo Clin Proc. 1995;70:113-118.  [PubMed]  [DOI]
82.  Welgan P, Meshkinpour H, Beeler M. Effect of anger on colon motor and myoelectric activity in irritable bowel syndrome. Gastroenterology. 1988;94:1150-1156.  [PubMed]  [DOI]
83.  Lasser RB, Bond JH, Levitt MD. The role of intestinal gas in functional abdominal pain. N Engl J Med. 1975;293:524-526.  [PubMed]  [DOI]
84.  King TS, Elia M, Hunter JO. Abnormal colonic fermentation in irritable bowel syndrome. Lancet. 1998;352:1187-1189.  [PubMed]  [DOI]
85.  Serra J, Azpiroz F, Malagelada JR. Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome. Gut. 2001;48:14-19.  [PubMed]  [DOI]
86.  Serra J, Azpiroz F, Malagelada JR. Gastric distension and duodenal lipid infusion modulate intestinal gas transit and tolerance in humans. Am J Gastroenterol. 2002;97:2225-2230.  [PubMed]  [DOI]
87.  Serra J, Salvioli B, Azpiroz F, Malagelada JR. Lipid-induced intestinal gas retention in irritable bowel syndrome. Gastroenterology. 2002;123:700-706.  [PubMed]  [DOI]
88.  Dainese R, Serra J, Azpiroz F, Malagelada JR. Effects of physical activity on intestinal gas transit and evacuation in healthy subjects. Am J Med. 2004;116:536-539.  [PubMed]  [DOI]
89.  Dainese R, Serra J, Azpiroz F, Malagelada JR. Influence of body posture on intestinal transit of gas. Gut. 2003;52:971-974.  [PubMed]  [DOI]
90.  Salvioli B, Serra J, Azpiroz F, Lorenzo C, Aguade S, Castell J, Malagelada JR. Origin of gas retention and symptoms in patients with bloating. Gastroenterology. 2005;128:574-579.  [PubMed]  [DOI]
91.  Passos MC, Serra J, Azpiroz F, Tremolaterra F, Malagelada JR. Impaired reflex control of intestinal gas transit in patients with abdominal bloating. Gut. 2005;54:344-348.  [PubMed]  [DOI]
92.  Oddsson E, Rask-Madsen J, Krag E. A secretory epithelium of the small intestine with increased sensitivity to bile acids in irritable bowel syndrome associated with diarrhoea. Scand J Gastroenterol. 1978;13:408-416.  [PubMed]  [DOI]
93.  Mellander A, Järbur K, Sjövall H. Pressure and frequency dependent linkage between motility and epithelial secretion in human proximal small intestine. Gut. 2000;46:376-384.  [PubMed]  [DOI]
94.  Sjövall H, Björnsson E, Mellander A, Simrén M. Positive Diagnosis of Diarrhea-Dominant Irritable Bowel Syndrome (d-IBS) by Combined Recording of Proximal Intestinal Motility and Transmucosal Potential Difference (PD). Gastroenterology. 2002;122:W1020.  [PubMed]  [DOI]
95.  Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut. 1973;14:125-132.  [PubMed]  [DOI]
96.  Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology. 1995;109:40-52.  [PubMed]  [DOI]
97.  Bradette M, Delvaux M, Staumont G, Fioramonti J, Bueno L, Frexinos J. Evaluation of colonic sensory thresholds in IBS patients using a barostat. Definition of optimal conditions and comparison with healthy subjects. Dig Dis Sci. 1994;39:449-457.  [PubMed]  [DOI]
98.  Costantini M, Sturniolo GC, Zaninotto G, D'Incà R, Polo R, Naccarato R, Ancona E. Altered esophageal pain threshold in irritable bowel syndrome. Dig Dis Sci. 1993;38:206-212.  [PubMed]  [DOI]
99.  Trimble KC, Farouk R, Pryde A, Douglas S, Heading RC. Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity. Dig Dis Sci. 1995;40:1607-1613.  [PubMed]  [DOI]
100.  Zighelboim J, Talley NJ, Phillips SF, Harmsen WS, Zinsmeister AR. Visceral perception in irritable bowel syndrome. Rectal and gastric responses to distension and serotonin type 3 antagonism. Dig Dis Sci. 1995;40:819-827.  [PubMed]  [DOI]
101.  Accarino AM, Azpiroz F, Malagelada JR. Selective dysfunction of mechanosensitive intestinal afferents in irritable bowel syndrome. Gastroenterology. 1995;108:636-643.  [PubMed]  [DOI]
102.  Holtmann G, Goebell H, Talley NJ. Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis. Am J Gastroenterol. 1997;92:954-959.  [PubMed]  [DOI]
103.  Bouin M, Lupien F, Riberdy M, Boivin M, Plourde V, Poitras P. Intolerance to visceral distension in functional dyspepsia or irritable bowel syndrome: an organ specific defect or a pan intestinal dysregulation. Neurogastroenterol Motil. 2004;16:311-314.  [PubMed]  [DOI]
104.  Chang L, Mayer EA, Johnson T, FitzGerald LZ, Naliboff B. Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia. Pain. 2000;84:297-307.  [PubMed]  [DOI]
105.  Rodrigues AC, Nicholas Verne G, Schmidt S, Mauderli AP. Hypersensitivity to cutaneous thermal nociceptive stimuli in irritable bowel syndrome. Pain. 2005;115:5-11.  [PubMed]  [DOI]
106.  Whitehead WE, Holtkotter B, Enck P, Hoelzl R, Holmes KD, Anthony J, Shabsin HS, Schuster MM. Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology. 1990;98:1187-1192.  [PubMed]  [DOI]
107.  Swarbrick ET, Hegarty JE, Bat L, Williams CB, Dawson AM. Site of pain from the irritable bowel. Lancet. 1980;2:443-446.  [PubMed]  [DOI]
108.  Prior A, Maxton DG, Whorwell PJ. Anorectal manometry in irritable bowel syndrome: differences between diarrhoea and constipation predominant subjects. Gut. 1990;31:458-462.  [PubMed]  [DOI]
109.  Whitehead WE, Engel BT, Schuster MM. Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients. Dig Dis Sci. 1980;25:404-413.  [PubMed]  [DOI]
110.  Kuiken SD, Lindeboom R, Tytgat GN, Boeckxstaens GE. Relationship between symptoms and hypersensitivity to rectal distension in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2005;22:157-164.  [PubMed]  [DOI]
111.  Schmulson M, Chang L, Naliboff B, Lee OY, Mayer EA. Correlation of symptom criteria with perception thresholds during rectosigmoid distension in irritable bowel syndrome patients. Am J Gastroenterol. 2000;95:152-156.  [PubMed]  [DOI]
112.  Distrutti E, Salvioli B, Azpiroz F, Malagelada JR. Rectal function and bowel habit in irritable bowel syndrome. Am J Gastroenterol. 2004;99:131-137.  [PubMed]  [DOI]
113.  Bouin M, Plourde V, Boivin M, Riberdy M, Lupien F, Laganière M, Verrier P, Poitras P. Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology. 2002;122:1771-1777.  [PubMed]  [DOI]
114.  Whitehead WE, Palsson OS. Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception. Gastroenterology. 1998;115:1263-1271.  [PubMed]  [DOI]
115.  Scarinci IC, McDonald-Haile J, Bradley LA, Richter JE. Altered pain perception and psychosocial features among women with gastrointestinal disorders and history of abuse: a preliminary model. Am J Med. 1994;97:108-118.  [PubMed]  [DOI]
116.  Corsetti M, Ogliari C, Marino B, Basilisco G. Perceptual sensitivity and response bias during rectal distension in patients with irritable bowel syndrome. Neurogastroenterol Motil. 2005;17:541-547.  [PubMed]  [DOI]
117.  Whitehead WE, Crowell MD, Davidoff AL, Palsson OS, Schuster MM. Pain from rectal distension in women with irritable bowel syndrome: relationship to sexual abuse. Dig Dis Sci. 1997;42:796-804.  [PubMed]  [DOI]
118.  Drossman DA, Leserman J, Nachman G, Li ZM, Gluck H, Toomey TC, Mitchell CM. Sexual and physical abuse in women with functional or organic gastrointestinal disorders. Ann Intern Med. 1990;113:828-833.  [PubMed]  [DOI]
119.  Ringel Y, Whitehead WE, Toner BB, Diamant NE, Hu Y, Jia H, Bangdiwala SI, Drossman DA. Sexual and physical abuse are not associated with rectal hypersensitivity in patients with irritable bowel syndrome. Gut. 2004;53:838-842.  [PubMed]  [DOI]
120.  Naliboff BD, Munakata J, Fullerton S, Gracely RH, Kodner A, Harraf F, Mayer EA. Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut. 1997;41:505-512.  [PubMed]  [DOI]
121.  Munakata J, Naliboff B, Harraf F, Kodner A, Lembo T, Chang L, Silverman DH, Mayer EA. Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome. Gastroenterology. 1997;112:55-63.  [PubMed]  [DOI]
122.  Bouhassira D, Sabaté JM, Coffin B, Le Bars D, Willer JC, Jian R. Effects of rectal distensions on nociceptive flexion reflexes in humans. Am J Physiol. 1998;275:G410-G417.  [PubMed]  [DOI]
123.  Coffin B, Bouhassira D, Sabaté JM, Barbe L, Jian R. Alteration of the spinal modulation of nociceptive processing in patients with irritable bowel syndrome. Gut. 2004;53:1465-1470.  [PubMed]  [DOI]
124.  Whitehead WE, Crowell MD, Robinson JC, Heller BR, Schuster MM. Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut. 1992;33:825-830.  [PubMed]  [DOI]
125.  Dickhaus B, Mayer EA, Firooz N, Stains J, Conde F, Olivas TI, Fass R, Chang L, Mayer M, Naliboff BD. Irritable bowel syndrome patients show enhanced modulation of visceral perception by auditory stress. Am J Gastroenterol. 2003;98:135-143.  [PubMed]  [DOI]
126.  Murray CD, Flynn J, Ratcliffe L, Jacyna MR, Kamm MA, Emmanuel AV. Effect of acute physical and psychological stress on gut autonomic innervation in irritable bowel syndrome. Gastroenterology. 2004;127:1695-1703.  [PubMed]  [DOI]
127.  Posserud I, Agerforz P, Ekman R, Björnsson ES, Abrahamsson H, Simrén M. Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut. 2004;53:1102-1108.  [PubMed]  [DOI]
128.  Simrén M, Månsson A, Langkilde AM, Svedlund J, Abrahamsson H, Bengtsson U, Björnsson ES. Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion. 2001;63:108-115.  [PubMed]  [DOI]
129.  Musial F, Crowell MD, Kalveram KT, Enck P. Nutrient ingestion increases rectal sensitivity in humans. Physiol Behav. 1994;55:953-956.  [PubMed]  [DOI]
130.  Erckenbrecht JF, Hemstege M, Rühl A, Krause J. The sensory component of the gastrocolonic response revisited: Postprandial colonic perception depends on meal composition. Gastroenterology. 1994;106:A494.  [PubMed]  [DOI]
131.  Caldarella MP, Milano A, Laterza F, Sacco F, Balatsinou C, Lapenna D, Pierdomenico SD, Cuccurullo F, Neri M. Visceral sensitivity and symptoms in patients with constipation- or diarrhea-predominant irritable bowel syndrome (IBS): effect of a low-fat intraduodenal infusion. Am J Gastroenterol. 2005;100:383-389.  [PubMed]  [DOI]
132.  Distrutti E, Hauer SK, Fiorucci S, Pensi MO, Morelli A. Intraduodenal lipids increase perception of rectal distension in IBS patients. Gastroenterology. 2000;118:A138.  [PubMed]  [DOI]
133.  Slater BJ, Plusa SM, Smith AN, Varma JS. Rectal hypersensitivity in the irritable bowel syndrome. Int J Colorectal Dis. 1997;12:29-32.  [PubMed]  [DOI]
134.  Steens J, Van Der Schaar PJ, Penning C, Brussee J, Masclee AA. Compliance, tone and sensitivity of the rectum in different subtypes of irritable bowel syndrome. Neurogastroenterol Motil. 2002;14:241-247.  [PubMed]  [DOI]
135.  Drewes AM, Petersen P, Rössel P, Gao C, Hansen JB, Arendt-Nielsen L. Sensitivity and distensibility of the rectum and sigmoid colon in patients with irritable bowel syndrome. Scand J Gastroenterol. 2001;36:827-832.  [PubMed]  [DOI]
136.  Aziz Q, Thompson DG. Brain-gut axis in health and disease. Gastroenterology. 1998;114:559-578.  [PubMed]  [DOI]
137.  Farthing MJ. Irritable bowel, irritable body, or irritable brain. BMJ. 1995;310:171-175.  [PubMed]  [DOI]
138.  Mayer EA, Chang L, Lembo T. Brain-gut interactions: implications for newer therapy. Eur J Surg Suppl. 1998;582:50-55.  [PubMed]  [DOI]
139.  Hobson AR, Aziz Q. Brain imaging and functional gastrointestinal disorders: has it helped our understanding. Gut. 2004;53:1198-1206.  [PubMed]  [DOI]
140.  Silverman DH, Munakata JA, Ennes H, Mandelkern MA, Hoh CK, Mayer EA. Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology. 1997;112:64-72.  [PubMed]  [DOI]
141.  Mertz H, Morgan V, Tanner G, Pickens D, Price R, Shyr Y, Kessler R. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology. 2000;118:842-848.  [PubMed]  [DOI]
142.  Verne GN, Himes NC, Robinson ME, Gopinath KS, Briggs RW, Crosson B, Price DD. Central representation of visceral and cutaneous hypersensitivity in the irritable bowel syndrome. Pain. 2003;103:99-110.  [PubMed]  [DOI]
143.  Yuan YZ, Tao RJ, Xu B, Sun J, Chen KM, Miao F, Zhang ZW, Xu JY. Functional brain imaging in irritable bowel syndrome with rectal balloon-distention by using fMRI. World J Gastroenterol. 2003;9:1356-1360.  [PubMed]  [DOI]
144.  Chang L, Berman S, Mayer EA, Suyenobu B, Derbyshire S, Naliboff B, Vogt B, FitzGerald L, Mandelkern MA. Brain responses to visceral and somatic stimuli in patients with irritable bowel syndrome with and without fibromyalgia. Am J Gastroenterol. 2003;98:1354-1361.  [PubMed]  [DOI]
145.  Naliboff BD, Derbyshire SW, Munakata J, Berman S, Mandelkern M, Chang L, Mayer EA. Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med. 2001;63:365-375.  [PubMed]  [DOI]
146.  Bonaz B, Baciu M, Papillon E, Bost R, Gueddah N, Le Bas JF, Fournet J, Segebarth C. Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study. Am J Gastroenterol. 2002;97:654-661.  [PubMed]  [DOI]
147.  Drossman DA. Brain imaging and its implications for studying centrally targeted treatments in irritable bowel syndrome: a primer for gastroenterologists. Gut. 2005;54:569-573.  [PubMed]  [DOI]
148.  Berman S, Munakata J, Naliboff BD, Chang L, Mandelkern M, Silverman D, Kovalik E, Mayer EA. Gender differences in regional brain response to visceral pressure in IBS patients. Eur J Pain. 2000;4:157-172.  [PubMed]  [DOI]
149.  Naliboff BD, Berman S, Chang L, Derbyshire SW, Suyenobu B, Vogt BA, Mandelkern M, Mayer EA. Sex-related differences in IBS patients: central processing of visceral stimuli. Gastroenterology. 2003;124:1738-1747.  [PubMed]  [DOI]
150.  Wilder-Smith CH, Schindler D, Lovblad K, Redmond SM, Nirkko A. Brain functional magnetic resonance imaging of rectal pain and activation of endogenous inhibitory mechanisms in irritable bowel syndrome patient subgroups and healthy controls. Gut. 2004;53:1595-1601.  [PubMed]  [DOI]
151.  Drossman DA, Ringel Y, Vogt BA, Leserman J, Lin W, Smith JK, Whitehead W. Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome. Gastroenterology. 2003;124:754-761.  [PubMed]  [DOI]
152.  Morgan V, Pickens D, Gautam S, Kessler R, Mertz H. Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome. Gut. 2005;54:601-607.  [PubMed]  [DOI]
153.  Berman SM, Naliboff BD, Chang L, Fitzgerald L, Antolin T, Camplone A, Mayer EA. Enhanced preattentive central nervous system reactivity in irritable bowel syndrome. Am J Gastroenterol. 2002;97:2791-2797.  [PubMed]  [DOI]
154.  Nomura T, Fukudo S, Matsuoka H, Hongo M. Abnormal electroencephalogram in irritable bowel syndrome. Scand J Gastroenterol. 1999;34:478-484.  [PubMed]  [DOI]
155.  Rössel P, Pedersen P, Niddam D, Arendt-Nielsen L, Chen AC, Drewes AM. Cerebral response to electric stimulation of the colon and abdominal skin in healthy subjects and patients with irritable bowel syndrome. Scand J Gastroenterol. 2001;36:1259-1266.  [PubMed]  [DOI]
156.  Sinhamahapatra P, Saha SP, Chowdhury A, Chakrabarti SK, Ghosh A, Maiti B. Visceral afferent hypersensitivity in irritable bowel syndrome--evaluation by cerebral evoked potential after rectal stimulation. Am J Gastroenterol. 2001;96:2150-2157.  [PubMed]  [DOI]
157.  Adeyemi EO, Desai KD, Towsey M, Ghista D. Characterization of autonomic dysfunction in patients with irritable bowel syndrome by means of heart rate variability studies. Am J Gastroenterol. 1999;94:816-823.  [PubMed]  [DOI]
158.  Karling P, Nyhlin H, Wiklund U, Sjöberg M, Olofsson BO, Bjerle P. Spectral analysis of heart rate variability in patients with irritable bowel syndrome. Scand J Gastroenterol. 1998;33:572-576.  [PubMed]  [DOI]
159.  Smart HL, Atkinson M. Abnormal vagal function in irritable bowel syndrome. Lancet. 1987;2:475-478.  [PubMed]  [DOI]
160.  van Orshoven NP, Andriesse GI, van Schelven LJ, Smout AJ, Akkermans LM, Oey PL. Subtle involvement of the parasympathetic nervous system in patients with irritable bowel syndrome. Clin Auton Res. 2006;16:33-39.  [PubMed]  [DOI]
161.  Gupta V, Sheffield D, Verne GN. Evidence for autonomic dysregulation in the irritable bowel syndrome. Dig Dis Sci. 2002;47:1716-1722.  [PubMed]  [DOI]
162.  Aggarwal A, Cutts TF, Abell TL, Cardoso S, Familoni B, Bremer J, Karas J. Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities. Gastroenterology. 1994;106:945-950.  [PubMed]  [DOI]
163.  Heitkemper M, Jarrett M, Cain KC, Burr R, Levy RL, Feld A, Hertig V. Autonomic nervous system function in women with irritable bowel syndrome. Dig Dis Sci. 2001;46:1276-1284.  [PubMed]  [DOI]
164.  Orr WC, Elsenbruch S, Harnish MJ. Autonomic regulation of cardiac function during sleep in patients with irritable bowel syndrome. Am J Gastroenterol. 2000;95:2865-2871.  [PubMed]  [DOI]
165.  Thompson JJ, Elsenbruch S, Harnish MJ, Orr WC. Autonomic functioning during REM sleep differentiates IBS symptom subgroups. Am J Gastroenterol. 2002;97:3147-3153.  [PubMed]  [DOI]
166.  Waring WS, Chui M, Japp A, Nicol EF, Ford MJ. Autonomic cardiovascular responses are impaired in women with irritable bowel syndrome. J Clin Gastroenterol. 2004;38:658-663.  [PubMed]  [DOI]
167.  Jarrett ME, Burr RL, Cain KC, Hertig V, Weisman P, Heitkemper MM. Anxiety and depression are related to autonomic nervous system function in women with irritable bowel syndrome. Dig Dis Sci. 2003;48:386-394.  [PubMed]  [DOI]
168.  Elsenbruch S, Orr WC. Diarrhea- and constipation-predominant IBS patients differ in postprandial autonomic and cortisol responses. Am J Gastroenterol. 2001;96:460-466.  [PubMed]  [DOI]
169.  Tillisch K, Mayer EA, Labus JS, Stains J, Chang L, Naliboff BD. Sex specific alterations in autonomic function among patients with irritable bowel syndrome. Gut. 2005;54:1396-1401.  [PubMed]  [DOI]
170.  Taché Y, Martinez V, Million M, Wang L. Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: role of brain corticotropin-releasing factor receptors. Am J Physiol Gastrointest Liver Physiol. 2001;280:G173-G177.  [PubMed]  [DOI]
171.  Dinan TG. Glucocorticoids and the genesis of depressive illness. A psychobiological model. Br J Psychiatry. 1994;164:365-371.  [PubMed]  [DOI]
172.  Böhmelt AH, Nater UM, Franke S, Hellhammer DH, Ehlert U. Basal and stimulated hypothalamic-pituitary-adrenal axis activity in patients with functional gastrointestinal disorders and healthy controls. Psychosom Med. 2005;67:288-294.  [PubMed]  [DOI]
173.  Dinan TG, Quigley EM, Ahmed SM, Scully P, O'Brien S, O'Mahony L, O'Mahony S, Shanahan F, Keeling PW. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker. Gastroenterology. 2006;130:304-311.  [PubMed]  [DOI]
174.  Chang L. Neuroendocrine and neuroimmune markers in IBS: pathophysiological role or epiphenomenon. Gastroenterology. 2006;130:596-600.  [PubMed]  [DOI]